Who is eligible for clinical trial NCT06893341?

Participants must meet protocol criteria for Diabetes. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06893341 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-05-08

Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events (NCT06893341)

🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Indiana University

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds in exhaled breath.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (8 items) and avoid the listed exclusions (8 items).

Location: Indiana University — Indianapolis, Indiana

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Who are diagnosed with type 1 diabetes.
Who are between 12-19 years of age.
That utilize a Dexcom (G6 or G7) continuous glucose monitoring device.
That have an established working CGM for at least 12 hours (that does not need to be replaced within 24 hours).
That are willing to share their daily CGM data for the study.
That are the only individuals in their household with any type of diabetes diagnosis (type 1 or type 2).
That are willing to return the device within 24-48 hours of study completion.
That are located in Indianapolis, IN or its suburban areas.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
That are smokers or use tobacco products or who live with someone who smokes in their vicinity.
That have a condition or abnormality other than type 1 diabetes that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data.
That utilize closed-loop diabetes management systems.
That have symptoms or recently been diagnosed with an upper respiratory illness including COVID-19.
That themselves or a close family member (living within the same household at the time of the data collection period) is on a "ketogenic diet".
That themselves or a close family member is working in an industry with high and continuous exposure to exogenous VOCs. Examples of such industries include beauty salons and paint manufacturers.
That are unable or unwilling to cooperate with sample collection.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Indiana University — Indianapolis, Indiana

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗